
================================================================================
=== DOCUMENT 1: 8-K - ahr-20250221.htm ===
================================================================================

ahr-20250221
FALSE
0001632970
12/31
0001632970
2025-02-21
2025-02-21
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
February 21, 2025
American Healthcare REIT, Inc.
(Exact name of registrant as specified in its charter)
Maryland
001-41951
47-2887436
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
18191 Von Karman Avenue
,
Suite 300
Irvine
,
California
92612
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code:
(
949
)
270-9200
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
AHR
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
Item 5.03 Regulation FD Disclosure.
On February 21, 2025, our board of directors, or our Board, approved and adopted the Second Amended and Restated Bylaws, or the Bylaws, which became effective upon adoption by our Board, to amend Article XIV of the Bylaws to provide stockholders with the power to adopt, alter or repeal any provision of the Bylaws and to make new Bylaws upon the affirmative vote of not less than a majority of all the votes entitled to be cast on the matter, as follows:
ARTICLE XIV
AMENDMENT OF BYLAWS
The Board of Directors shall have the power to adopt, alter or repeal any provision of these Bylaws and to make new Bylaws. In addition, the stockholders shall have the power, by the affirmative vote of not less than a majority of all the votes entitled to be cast on the matter, to adopt, alter or repeal any provision of these Bylaws and to make new Bylaws.
The foregoing description of the Bylaws does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Bylaws, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K, and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
3.1
American Healthcare REIT, Inc. Second Amended and Restated Bylaws
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
American Healthcare REIT, Inc.
February 24, 2025
By:
/s/ Danny Prosky
Name: Danny Prosky
Title: Chief Executive Officer and President

